Dr. Alvarez-Breckenridge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1400 Holcombe Boulevard
Room FC7.2000, Unit 442
Houston, TX 77030Phone+1 614-747-0723- Is this information wrong?
Summary
- Christopher Alvarez-Breckenridge, M.D., Ph.D., is an assistant professor within MD Anderson Cancer Center’s Department of Neurosurgery with expertise in spinal tumors, particularly metastatic disease and immunotherapy. He was a member of the Medical Scientist Training Program (MSTP) at The Ohio State University where he received his combined M.D./Ph.D., and his doctoral research focused on oncolytic viral therapy for gliomas. He subsequently completed residency in neurosurgery at Massachusetts General Hospital. During that time, he was awarded the Massachusetts General Hospital Neurosurgery Research Award and the American Association of Neurological Surgeons Journal of Neuro-Oncology Award for his research on immunotherapy for brain metastases and leptomeningeal disease. Dr. Alvarez-Breckenridge became a fellow in Neurosurgical Oncology at The University of Texas MD Anderson Cancer Center in 2020 where he worked and learned alongside experts within the institution. His surgical practice focuses on tumors of the spine, and he is eager to build upon his prior research experiences to develop an immuno-oncology focused translational research program.
Education & Training
Massachusetts General HospitalResidency, Neurological Surgery, 2013 - 2020
Ohio State University College of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2020 - 2025
MA State Medical License 2013 - 2021
Awards, Honors, & Recognition
- Early Clinical Investigator Award Cancer Prevention & Research Institute of Texas (CPRIT), 2022
- Arthur and Sandra Irving Cancer Immunology Symposium Promising Young Scientist Massachusetts General Hospital, 2022
- Physician-Scientist Program MD Anderson Cancer Center, 2022
- Join now to see all
Publications & Presentations
PubMed
- Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebra...Mihir D Shanker, Adriana P Cavazos, Jing Li, Thomas H Beckham, Debra N Yeboa, Chenyang Wang, Mary Frances McAleer, Tina Marie Briere, Behrang Amini, Claudio E Tatsui, ...> ;Radiotherapy and Oncology. 2024 Apr 1
- Tumor treating fields suppress tumor cell growth and neurologic decline in models of spine metastases.Daniel Ledbetter, Romulo de Almeida, Xizi Wu, Ariel Naveh, Queena Gonzalez, Thomas H Beckham, David Aten, Chirag B Patel, Robert North, Laurence Rhines, Jing Li, Amol ...> ;JCI Insight. 2024 Mar 21
- Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium.Christopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia, Shadmehr Demehri, Huy Q Dinh, Karen Olivia Dixon, Gavin P Dunn, Laura Evgin, Jeremy Goc, Zinai...> ;Cancer Immunology Research. 2023 Dec 1
- Join now to see all
Press Mentions
CPRIT Awards $2.5 Million to Support MD Anderson Cancer ResearchSeptember 14th, 2022
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
